Get notified when AIDX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alerts20/20 Biolabs files prospectus for resale of 10.1M shares by selling stockholders; stock at $0.549
Filed August 17, 2026 · ~1 min read
Key Changes
-
high
The prospectus covers resale of up to 10,105,000 shares by selling stockholders; the company receives no proceeds from these sales.
The Offering verify on EDGAR → -
medium
On August 14, 2026, the closing price of the common stock on Nasdaq was $0.549.
The Offering verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.
Partner
Trade AIDX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify